Bank of Montreal
WST icon

Bank of Montreal’s West Pharmaceutical WST Stock Holding History

Bank of Montreal’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Hold
1,200
– – ﹤0.01% 2542
2026
Q1 		$301K Buy
+1,200
New +$299K ﹤0.01% 2683

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bank of Montreal's WST Position: Q2 2026 in Review

Bank of Montreal increased its West Pharmaceutical (WST) stake by 8.3% in Q2 2026, buying an estimated $3.23M and bringing the position to 137,753 shares worth $49.5M. The position accounts for 0.02% of the portfolio, ranked #610.

Bank of Montreal first reported a position in WST in Q2 2013 and has held it in 53 quarters since. The position peaked at $73.4M in Q2 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bank of Montreal held 137,753 shares of West Pharmaceutical worth $49.5M as of Q2 2026.
  • Bank of Montreal bought 10,579 West Pharmaceutical shares in Q2 2026, an estimated $3.23M.
  • West Pharmaceutical made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #610 holding.
  • Bank of Montreal first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's West Pharmaceutical position peaked at $73.4M in Q2 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.